gastric cancer

You have access
Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening
SUNG EUN OH, MI YUN OH, SU MI KIM, SUN YOUNG KIM, JI YEONG AN, JUN HO LEE, TAE SUNG SOHN, JAE MOON BAE and MIN-GEW CHOI

Anticancer Research June 2022, 42 (6) 2883-2891; DOI: https://doi.org/10.21873/anticanres.15770
Open Access
Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI

Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
You have access
Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study
KEISUKE KOMORI, KAZUKI KANO, TAKANOBU YAMADA, HAYATO WATANABE, KOSUKE TAKAHASHI, YUKIO MAEZAWA, HIROHITO FUJIKAWA, MASAKATSU NUMATA, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA and TAKASHI OSHIMA

Anticancer Research May 2022, 42 (5) 2719-2725; DOI: https://doi.org/10.21873/anticanres.15750
Open Access
Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
EDOARDO VIRGILIO, FILIPPO MONTALI, ALFREDO ANNICCHIARICO, CARLO SALVEMINI, MANUEL BALDINU, ENRICO GIARNIERI, MONICA MONTAGNINI, SANDRA VILLANI, ANTONELLA PROIETTI, ROSARIA D’URSO and RENATO COSTI

Anticancer Research May 2022, 42 (5) 2249-2259; DOI: https://doi.org/10.21873/anticanres.15705
Open Access
Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells
AKIRA ISHIKAWA, KAZUYA KURAOKA, JUNICHI ZAITSU, AKIHISA SAITO, TOSHIO KUWAI, HIROFUMI TAZAWA, TAKAHISA SUZUKI, HIROTAKA TASHIRO, KIYOMI TANIYAMA and WATARU YASUI

Anticancer Research April 2022, 42 (4) 1707-1717; DOI: https://doi.org/10.21873/anticanres.15647
You have access
Association of Matrix Metallopeptidase-2 Genotypes With Risk of Gastric Cancer in Taiwan
CHUN-KAI FU, MEI-CHIN MONG, CHIEN-CHIH YU, MEI-DUE YANG, ZHI-HONG WANG, YA-CHEN YANG, JAW-CHYUN CHEN, JEN-SHENG PEI, NING-YI HSIA, CHIA-WEN TSAI, WEN-SHIN CHANG and DA-TIAN BAU

Anticancer Research April 2022, 42 (4) 1749-1755; DOI: https://doi.org/10.21873/anticanres.15651
Open Access
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA

Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
You have access
The Significance of Surgical Intervention for Metasynchronous Liver Metastasis in Gastric Cancer: A Single-centre Analysis
TAKEHIKO HANAKI, TEPPEI SUNAGUCHI, KEISUKE GOTO, MASAKI MORIMOTO, YUKI MURAKAMI, YUJI SHISHIDO, KOZO MIYATANI, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, MANABU YAMAMOTO, NARUO TOKUYASU, TERUHISA SAKAMOTO, TOSHIMICHI HASEGAWA and YOSHIYUKI FUJIWARA

Anticancer Research April 2022, 42 (4) 2177-2184; DOI: https://doi.org/10.21873/anticanres.15700
You have access
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab
HIDEAKI SUEMATSU, KAZUKI KANO, TAKANOBU YAMADA, ITARU HASHIMOTO, HAYATO WATANABE, KOSUKE TAKAHASHI, MAMORU WATANABE, KEI HAYASHI, YOSHIHIRO KANETA, MITSUHIRO FURUTA, YASUHIRO INOKUCHI, NOZOMU MACHIDA, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA and TAKASHI OSHIMA

Anticancer Research March 2022, 42 (3) 1535-1540; DOI: https://doi.org/10.21873/anticanres.15626
You have access
Prognostic Predictors After Surgical Intervention for Stage IV Gastric Cancer
SATOSHI SUZUKI, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI and YOSHIHIRO KAKEJI

Anticancer Research March 2022, 42 (3) 1541-1546; DOI: https://doi.org/10.21873/anticanres.15627

Main menu

User menu

Search

gastric cancer

Pages